Logo

American Heart Association

  13
  0


Final ID: Sa3039

Incidence of Heart Failure Among Hispanic/Latino Individuals in the United States: Insights from the Hispanic Community Health Study/Study of Latinos

Abstract Body (Do not enter title and authors here): Introduction:
Hispanic/Latino individuals are known to have higher traditional cardiovascular disease (CVD) risk factors compared to non-Hispanic Whites and Asians. However, inconsistencies and variability exist regarding the incidence of heart failure (HF) among Hispanics compared to other race/ethnic groups. We examined the incidence of HF in participants enrolled in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Methods:
The baseline HCHS/SOL population consisted of 16,415 participants enrolled between 2008 - 2011 and followed up for incident HF events through 2015 (mean follow up period of 5.8 years). A total of 1000 participants with pre-existing HF at baseline, or with missing information/response for baseline HF, socio-economic status (SES), CVD risk factors, and medication use were excluded. Outcome was ascertained via self-report of events at annual follow-up interviews. HF events were adjudicated by trained physicians who reviewed hospital records. HCHS/SOL participants were stratified into seven Hispanic/Latino heritage groups: Mexican, Dominican, Cuban, Puerto Rican, South or Central American, as well as more than one/other. Cox-proportional hazard regression models were used to calculate HRs for incident HF with Mexican Americans as the reference group and controlling for SES, CVD risk factors, and medication use.

Results:
A total of 15,415 participants [mean age 41 years, 52.2% Female) were included and 114 HF events (69 Males and 45 Females) were identified after 89,751 person-years follow up. The HF incidence rate was 94.6 per 100,000 persons-years. Hispanic/Latino individuals of Cuban background had the highest HF incidence rate (131.4 per 100,000 person-years) while those from Central American backgrounds had the lowest (42.8 per 100,000 person-years). Hispanic/Latino individuals of Cuban background [HR: 1.471 (95% C.I: 0.397,5.447)] and Dominican background [HR: 0.509 (95% C.I: 0.075, 3.429)] had the highest and lowest adjusted HR of incident HF compared to those of Mexican background.

Conclusion:
Among different Hispanic/Latino heritage groups, the incidence rate for HF was highest among those with Cuban background and lowest among those with a Central American background.
  • Nriagu, Bede  ( New York Medical Coll-Metropolitan , New York , New York , United States )
  • Hurwitz, Barry  ( UNIVERSITY OF MIAMI , Miami , Florida , United States )
  • Chavez, Patricia  ( Yale New Haven Health , Greenwich , Connecticut , United States )
  • Aviles-santa, Larissa  ( NHLBI , Bethesda , Maryland , United States )
  • Solomon, Scott  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Cheng, Susan  ( Cedars-Sinai Medical Center , Los Aeles , California , United States )
  • Shook-sa, Bonnie  ( University of North Carolina , Chapel Hill , North Carolina , United States )
  • Cai, Jianwen  ( UNC Chapel Hill , Chapel Hill , North Carolina , United States )
  • Gallo, Linda  ( San Diego State University , Chula Vista , California , United States )
  • Rodriguez, Carlos  ( Albert Einstein School of Medicine , Bronx , New York , United States )
  • Duran Luciano, Priscilla  ( Albert Einstein College of Medicine , Bronx , New York , United States )
  • Pandey, Ambarish  ( UTSW MEDICAL CENTER , Dallas , Texas , United States )
  • Daviglus, Martha  ( UNIVERSITY ILLINOIS CHICAGO , Chicago , Illinois , United States )
  • Talavera, Gregory  ( SAN DIEGO STATE UNIVERSITY , Chula Vista , California , United States )
  • Kaplan, Robert  ( Albert Einstein College of Medicine , Bronx , New York , United States )
  • Shah, Sanjiv  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
  • Allison, Matthew  ( University of California San Diego , La Jolla , California , United States )
  • Kizer, Jorge  ( San Francisco VA , San Francisco , California , United States )
  • Author Disclosures:
    Bede Nriagu: DO NOT have relevant financial relationships | Barry Hurwitz: DO NOT have relevant financial relationships | Patricia Chavez: No Answer | Larissa Aviles-Santa: DO NOT have relevant financial relationships | Scott Solomon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos/BridgeBio, Gossamer, GSK, Ionis, Lilly,NIH/NHLBI, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, US2.AI:Active (exists now) ; Consultant:Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, GSK, Intellia, Lilly, Novartis, Roche, Theracos, Quantum Genomics, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, Valo:Active (exists now) | Susan Cheng: DO have relevant financial relationships ; Consultant:UCB:Active (exists now) | Bonnie Shook-Sa: DO NOT have relevant financial relationships | Jianwen Cai: DO NOT have relevant financial relationships | Linda Gallo: DO NOT have relevant financial relationships | Carlos Rodriguez: DO NOT have relevant financial relationships | Priscilla Duran Luciano: DO NOT have relevant financial relationships | Ambarish Pandey: DO have relevant financial relationships ; Consultant:Tricog:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:Semler:Active (exists now) ; Consultant:Science37:Active (exists now) ; Research Funding (PI or named investigator):SCPharma:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Advisor:Axon:Active (exists now) ; Advisor:Bayer:Active (exists now) ; Research Funding (PI or named investigator):Ultromics:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Roche:Active (exists now) | Martha Daviglus: DO NOT have relevant financial relationships | Gregory Talavera: DO NOT have relevant financial relationships | Robert Kaplan: No Answer | Sanjiv Shah: DO have relevant financial relationships ; Consultant:Bayer:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Axon Therapies:Active (exists now) ; Consultant:Corvia :Active (exists now) ; Consultant:Boehringer-Ingelheim:Active (exists now) ; Consultant:Bristol-Myers Squibb:Active (exists now) ; Consultant:Ionis:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Tenax:Active (exists now) ; Consultant:Intellia:Active (exists now) ; Consultant:Rivus:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) | Matthew Allison: DO NOT have relevant financial relationships | JORGE KIZER: DO have relevant financial relationships ; Individual Stocks/Stock Options:Abbott:Past (completed) ; Individual Stocks/Stock Options:Pfizer:Past (completed) ; Individual Stocks/Stock Options:Merck:Past (completed) ; Individual Stocks/Stock Options:Medtronic:Past (completed) ; Individual Stocks/Stock Options:Lilly:Past (completed) ; Individual Stocks/Stock Options:Johnson & Johnson:Past (completed) ; Individual Stocks/Stock Options:Bristol Myers Squibb:Past (completed) ; Individual Stocks/Stock Options:AbbVie:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Breaking Barriers: Addressing Health Disparities for Improved Outcomes

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
More abstracts from these authors:
Impact of Allostatic Load on Prevalent and Incident Pre-Heart Failure in the Echocardiographic Study of Latinos (ECHO-SOL)

Hirsch Eric, Kansal Mayank, Talavera Gregory, Perreira Krista, Rodriguez Carlos, April-sanders Ayana, Duran Luciano Priscilla, Yuan Yawen, Isasi Carmen, Gallo Linda, Hurwitz Barry, Daviglus Martha, Shook-sa Bonnie

Preclinical Heart Failure Risk of Metabolically Healthy Overweight/Obese Adults in Hispanic/Latino Adults.

Krueger Mason, April-sanders Ayana, Talavera Gregory, Hurwitz Barry, Llabre Maria, Schneiderman Neil, Kaplan Robert, Rodriguez Carlos, Daviglus Martha, Cai Jianwen, Cheng Susan, Kansal Mayank

You have to be authorized to contact abstract author. Please, Login
Not Available